Name | N,N,2-trimethyl-5-nitrobenzenesulfonamide |
Synonyms | -50481 BRL 50481 N,N,2-trimethyl-5-nitrobenzenesulfonamide N,N,2-Trimethyl-5-nitrobenzenesulfonamide 5-NITRO-2,N,N-TRIMETHYLBENZENESULFONAMIDE N,N,2-trimethyl-5-nitro-benzenesulfonamide N,N,2-TRIMETHYL-5-NITRO-BENZENESULFONAMIDE Benzenesulfonamide, N,N,2-trimethyl-5-nitro- 3-(N,N-Dimethylsulfonamido)-4-methylnitrobenzene,5-Nitro-2-N,N-trimethylbenzenesulfonamide |
CAS | 433695-36-4 |
EINECS | 1592732-453-0 |
InChI | InChI=1/C9H12N2O4S/c1-7-4-5-8(11(12)13)6-9(7)16(14,15)10(2)3/h4-6H,1-3H3 |
Molecular Formula | C9H12N2O4S |
Molar Mass | 244.27 |
Density | 1.334±0.06 g/cm3(Predicted) |
Melting Point | 65-67°C |
Boling Point | 391.1±52.0 °C(Predicted) |
Flash Point | 190.4°C |
Solubility | DMSO: 12mg/mL |
Vapor Presure | 2.52E-06mmHg at 25°C |
Appearance | solid |
Color | white |
pKa | -5?+-.0.70(Predicted) |
Storage Condition | 2-8°C |
Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months. |
Refractive Index | 1.561 |
Use | This product is for scientific research only and shall not be used for other purposes. |
In vitro study | BRL-50481 increases the cAMP content (19.1±6.2% of IBMX response at 300 μM) but is considerably less potent. BRL-50481 (30 μM) fails to suppress proliferation by itself but significantly potentiates the effect of rolipram. BRL-50481 (30 μM) has no effect on IL-15-induced proliferation but augments the inhibitory effect of rolipram. Pretreatment (30 min) of human monocytes with BRL-50481 has, by itself, a negligible (~2 to 10%) inhibitory effect on TNFα output at all concentrations tested. BRL-50481 also potentiates the inhibitory effect of PGE 2 on LPS-induced TNFα release. BRL-50481 has no significant effect by itself on κB-dependent transcription (5.6±1.9% inhibition at 30 μM) and fails to enhance the effect of rolipram (maximum inhibition, 52.9±2.7%; pIC 30 value of 5.33±0.12). BRL-50481 suppresses, in a concentration-dependent manner, LPS-induced TNFα release in monocytes in which PDE7A1 is induced (21.7±1.6% inhibition at 30 μM at the 12-h time point). |
WGK Germany | 3 |